Applied Dna Sciences Inc (NASDAQ:BNBX) Sees Large Decline in Short Interest

Applied Dna Sciences Inc (NASDAQ:BNBXGet Free Report) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totaling 116,017 shares, a decline of 50.0% from the April 30th total of 231,818 shares. Approximately 1.7% of the shares of the company are sold short. Based on an average trading volume of 58,204 shares, the days-to-cover ratio is currently 2.0 days.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Applied Dna Sciences in a research note on Friday, April 24th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

Get Our Latest Stock Analysis on BNBX

Applied Dna Sciences Trading Down 0.9%

Shares of NASDAQ:BNBX traded down $0.00 during mid-day trading on Tuesday, reaching $0.54. 363,912 shares of the company traded hands, compared to its average volume of 610,097. The stock’s 50 day simple moving average is $0.54. The company has a market capitalization of $3.92 million, a price-to-earnings ratio of -0.01 and a beta of 0.58. Applied Dna Sciences has a 52 week low of $0.35 and a 52 week high of $7.15.

Applied Dna Sciences (NASDAQ:BNBXGet Free Report) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.68) earnings per share (EPS) for the quarter. The company had revenue of $1.02 million for the quarter. Applied Dna Sciences had a negative net margin of 1,647.25% and a negative return on equity of 349.95%.

About Applied Dna Sciences

(Get Free Report)

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.

See Also

Receive News & Ratings for Applied Dna Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Dna Sciences and related companies with MarketBeat.com's FREE daily email newsletter.